|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 26, 2017 ) The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, AstraZeneca entered into a deal with WuXi to acquire its biologics manufacturing facilities in China to expand locally.
Publisher's analysts forecast the global pharmerging market to grow at a CAGR of 12.88% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-pharmerging-markets-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global pharmerging market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of pharmaceutical drugs in pharmerging markets, which are further divided into Tier I, II and III.
The market is divided into the following segments based on geography:
- Tier 1
- Tier 2
- Tier 3
Publisher's report, Global Pharmerging Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AstraZeneca
- GlaxoSmithKline
- Pfizer
- Sanofi
- Novartis
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001563243/sample .
Other prominent vendors
- Abbott Laboratories
- AbbVie
- Alexion Pharmaceuticals
- Allergan
- Amgen
- Aspen
- Astellas Pharma
- Baxter
- Bayer
- Biogen
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- CSL Behring
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- Eisai
- Eli Lilly
- Endo Health Pharmaceuticals
- F. Hoffmann-La Roche
- Fresenius
- Gilead
- Grifols
- H. Lundbeck
- Hospira
- Johnson & Johnson
- Kyowa Hakko Kirin
- Mallinckrodt Pharmaceuticals
- Menarini
- Mitsubishi Tanabe Pharma
- Mylan
- Novo Nordisk
- Otsuka
- Shire
- STADA Arzneimittel
- Sun Pharmaceutical
- Takeda Pharma
- Teva Pharmaceutical Industries
- UCB
- Valeant Pharmaceuticals
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001563243/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
